Background: Type D personality has been proposed as a prognostic indicator for
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Starting with an often-cited Lancet article (1), Type D personality, which has been defined as the tendency to experience negative emotions and to inhibit self-expression in social interaction, has been proposed as a prognostic indicator for mortality in CVD independent of biological factors, including disease severity. However, the original Lancet study excluded deaths in the first five years, with an observation period of [6] [7] [8] [9] [10] [11] [12] years. After exclusion of these 93 patients, only 21 deaths remained to be explained, too few events to justify the multivariate regression analyses, which were thus overfitted, with a high risk of spurious findings (2) . A series of subsequent studies mostly had small samples, inconsistent scoring of the Type D measure, varying start and length of follow up periods, and overfitted regression equations, with 6 (3), 8 (4), 12 (5) and 4 (6,) deaths, respectively, being explained. These studies tended to have fewer events being explained than the number of covariates considered for entering into multivariate analyses. A later study reported on 47 deaths in a mean observation period of 30 months among heart failure patients and found a significant effect for Type D (OR=2.16; 95%CI:1.05-4.43, p=.04) that did not persist when confounds were controlled (7) . More recently, Type D was not found to predict 123 deaths among 641 heart failure (HF) patients in bivariate or multivariate analyses (8) . It is noteworthy that thus far all studies relating Type D personality to mortality, were conducted by the one investigator group, with the exception of one small study in which there were null findings, but only 11 deaths to explain (9) .
Proposals have nonetheless been made for routine screening of CVD patients for Type D personality (10) and use of Type D for stratification purposes (11) . The clinical utility of this variable remains to be independently established. We undertook an evaluation of Type D personality as a predictor of mortality among HF patients, taking 5 advantage of a large scale clinical trial with almost as many events (death) as all previous Type D mortality studies combined. Assessments of patients were also available with a biomarker, B-type natriuretic peptide (BNP) that has emerged as a reliable indicator of severity of HF (12, 13) , and assessment of depressive symptoms, an established prognostic indicator for clinical outcomes in coronary heart disease and heart failure (14) .
Methods

Study design
This report draws on data from the previously reported COACH trial in the Netherlands (15, 16) , a multicentre, randomized controlled trial with blinded end-point evaluation, designed to evaluate the effects of disease management, i.e., advising and counselling of patients with HF. The COACH trial revealed no significant treatment effects on mortality (16), Patients were assessed for Type D at baseline (during hospitalization) and followed for mortality for 18 months thereafter.
Study population
Patients were recruited between October 2002 and February 2005 while hospitalized for symptomatic HF (NYHA II-IV). Patients were required to be at least 18 years old and have evidence of structural underlying heart disease. Patients with impaired and preserved left ventricular function (LVEF) were included. Major exclusion criteria were concurrent inclusion in another study or HF clinic, inability to complete questionnaires, invasive procedures or cardiac surgery performed within the last 6 months or planned within the next 3 months, ongoing evaluation for heart transplantation and inability or unwillingness to give informed consent. Of the 958 patients enrolled in the trial, 706 had complete data for BNP, depressive symptoms, and Type D personality and so were included in the present analyses.
Once informed consent was signed, baseline data collection started and afterwards patients were randomized into 1 of 3 groups; basic support, intensive support or the control group. The study complied with the Declaration of Helsinki and the protocol was reviewed and approved by a central appointed ethics committee.
Data collection
Data on mortality were collected from medical records. All reported deaths were reviewed by an independent clinical end-point committee who defined the date and cause of death.
Type D personality was assessed at baseline using the Type D scale (DS14), consisting of two 7-item subscales, i.e. negative affectivity and social inhibition (17) . As customary, patients were defined as Type-D when scoring ≥ 10 on both subscales. The DS14 is generally construed as measuring two temporally stable personality traits, as indicated by good test-retest reliability and to be independent from changes in mood (17) .
Depressive Symptoms were assessed at baseline with the Center for Epidemiologic Studies -Depression Scale (18, 19) , a 20-item, well-validated measure that is commonly used with cardiac patients. Scores range from 0-60 and a validated cutpoint > 16 is typically used to distinguish between low and high depressive symptomatology.
BNP measurement. BNP measurement in this sample is described elsewhere (20) .
Basically, BNP plasma levels were determined using a Triage®; fluorescence immunoassay kit within 4 hours of blood collection on the day of hospital discharge or one day before hospital discharge. For simplifying interpretation, BNP values were divided by 1000. Patients with available BNP levels did not differ for demographic or clinical characteristics, and rates of Type D personality were not significantly different (p= .56) between patients with available BNP levels (13%; n=721) and patients who did not have a BNP measurement (12%; n=237).
Statistical analysis.
Descriptive sample statistics for baseline characteristics for the full sample were calculated, as well as prevalence of Type D personality and the relationship between Type D classification and key variables. Bivariate associations of Type D classification and mortality were calculated.
A Cox proportional hazards model was constructed for Type D personality. BNP and depressive symptoms were entered as the first block in an equation predicting mortality, with the entry of Type D in the second block testing the hypothesis that Type D classification had significant added prognostic value. Other potential control variables were considered, but had to meet the requirement of being related to both Type D personality and mortality, but also as potentially preceding or determining both Type D personality and mortality. We thus did not evaluate potential mediators of Type D on mortality as confounders (21, 22) .
Taxometric analyses (23) suggest that Type D is better represented as a dimensional rather than categorical construct. Moreover, there is a long-standing consensus among psychometricians and personality theorists that the practice of dichotomizing two continuous variables and constructing a typology in terms of a resulting 2 × 2 matrix of high-low groups is variously unnecessary, highly problematic, and prone to spurious associations and therefore should be avoided (24, 25, 26, 27) . We therefore also analyzed the arguably more appropriate prediction of mortality from zscores for the component negative affectivity and social inhibition and their interaction term.
Results
Baseline Characteristics. The present analyses included 706 patients who had BNP assessments and CES-D scores and completed all 14 questions of the DS14. Analyses of differences between the 706 patients and the larger sample of 958 participants in the COACH trial from which they were drawn revealed differences only in that patients included in the study were lower in prescription of antidepressants, (6.1% vs 9.9%), ttest, p< .04. In total, 95 patients (13%) in the present sample were identified as having a Type D personality. Baseline characteristics of the study sample are provided in Table 1 .
Mean age of the study sample was 70.7 years and 38.2% were women. At hospital discharge, 49.4% of the patients were classified as having NYHA functional class II disease and 50.6% as having NYHA III or IV disease. A total of 43.2 % had ischemic heart failure with a history of a myocardial infarction. As seen in Table 3 , BNP and CES-D scores were entered as a first block in a Cox proportional hazards analysis, and the overall block proved a significant predictor of mortality, but this was due to the contribution of BNP, with the contribution of CES-D scores not significant (model 1). In model 2, the dichotomous variable Type-D was added. This did not improve the prediction of mortality. Table 4 again starts with a model with BNP and CES-D scores (model 1). This time, in model 2, the two components of Type D, negative affection and social inhibition (zscores), were entered together with their interaction. The interaction term was not significant in improving the prediction of mortality, again indicating that Type-D did not contribute to the prediction of mortality when using continuous scores. In order to interpret the main effects of negative affection and social inhibition, the interaction term was removed, resulting in the final model 3. BNP appeared to be the best predictor of mortality. Depression also predicted mortality, but to a limited degree. Initial Cox proportion hazards models in our study were constructed consistent with all past studies testing the prognostic value of Type D for mortality, namely, with Type D treated as a typology with patients high in both negative affectivity and social inhibition being contrasted with the other three quadrants in a high-low, 2 x 2 cross tabulation of negative affectivity and social inhibition. Next, we obtained the same null results in our treatment of Type D in terms of the interaction between continuous negative affectivity and social inhibition z-scores. However, our second analytic strategy is more defensible and appropriate, given not only conclusions of taxometric analyses that indicate that Type D is best construed in continuous, dimensional terms rather than a typology, but a consensus that has emerged over 30 years in the psychometric and personality theory literature that typologies created from high-low, 2 x 2 crossings of continuous dimensional variables are inappropriate and prone to spurious findings (24, 25, 26, 27) .
We find these arguments compelling and suggest that future Type D personality research adopt our analytic strategy of focusing on the interaction of negative affectivity and social inhibition or explain why it is not being adopted.
In our present sample, depressive symptoms were not a significant predictor of mortality, although the association was in the expected direction. However, the present sample was limited to patients for whom both BNP and assessment of Type D personality were available (N= 706). These patients were drawn from a larger sample (N= 938) in which depressive symptoms were modestly associated with morality (HR 1.169, P = 0.02) (20) . The larger literature is mixed concerning the prediction of mortality in heart failure from depressive symptoms, particularly when mortality is examined separately, rather than simply treated as one aspect of a composite endpoint. A recent review of studies of the association of depressive symptoms and mortality in heart failure reported null findings for inpatient samples, but most studies of outpatients finding an association (29) . The present sample was recruited and assessed during an inpatient stay.
The strong association between one component of Type D, negative affectivity, and both depressive symptoms and use of antidepressants raises the possibility that in addition to preserving the components of Type D as continuous variables, future research should examine whether depressive symptoms could be substituted for negative affectivity without any substantial loss of predictive power with respect to clinical variables. The association between depressive symptoms and cardiovascular outcomes is stronger and based on a more substantial literature than is the case for Type D. Routine screening for depression in cardiovascular patients has already been recommended by a number of professional organizations (30) , even if the benefits of screening for cardiovascular outcomes are yet to be established (31) . Furthermore, it is unlikely that calls for screening for Type D (11) will lead to the DS-14 supplanting measures of depression. Non-mental health clinicians are notably averse to introducing and sustaining routine psychological screening (32) and report even brief depression screening measures such as the PHQ-9 are too long (33, 34) . If however, it could be shown that a brief, 7-item measure of social inhibition added substantially to the predictive ability of depressive symptoms, perhaps screening for social inhibition could be added to screening for depression.
Null findings from one large study might be contradicted by subsequent studies, but we note important limitations in the small studies that have been cited in support of a prognostic value for Type D personality with respect to mortality. Claims for the prognostic value of Type D may fit the pattern of other psychosocial variables purportedly predicting mortality, for instance, fighting spirit in the prediction of mortality of cancer patients (35) . Namely, initial claims are based on underpowered studies, but cannot be validated in subsequent large scale studies with appropriate control of biomedical variables. Reasons for the rise, persistence and ultimate fall of such hypotheses are undoubtedly varied. They likely include early positive results capitalizing on chance or multivariate analyses where bivariate associations are not significant, and methodological limitations of the small studies, as well as publication bias (36, 37) .
Supporting the hypothesis of a publication bias, we note that previous positive studies have had 4 to 21 deaths to be explained, too few to justify the multivariate analyses that were employed. Moreover, such a small number of deaths being explained in the individual studies could not be expected to generate a consistent pattern of positive findings unless an exceptionally large and unprecedented effect of personality on mortality were present.
This study had the advantage of an adequate sample size and being the first study with regard to mortality conducted outside the original Type D investigator group. Some of the patients included in this study were from the same clinical settings providing patients to the earlier studies and the remainder were drawn from the same larger Note: Continuous score for depression was used. 
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